Free Trial

Adaptive Biotechnologies (ADPT) SEC Filings & 10K Form

Adaptive Biotechnologies logo
$4.42 -0.06 (-1.34%)
(As of 11/20/2024 ET)

Recent Adaptive Biotechnologies SEC Filings

DateFilerForm TypeView
11/19/2024
5:45 PM
Adaptive Biotechnologies (Issuer)
PISKEL KYLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
3:30 PM
Adaptive Biotechnologies (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13G
11/13/2024
8:00 AM
Adaptive Biotechnologies (Subject)
Matrix Capital Management Company, LP (Filed by)
Form SC 13G/A
11/12/2024
12:30 PM
Adaptive Biotechnologies (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/08/2024
2:15 PM
Adaptive Biotechnologies (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
Form SC 13G
11/07/2024
3:30 PM
Adaptive Biotechnologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
5:07 AM
Adaptive Biotechnologies (Subject)
Sumitomo Mitsui Trust Group, Inc. (Filed by)
Form SC 13G
11/04/2024
9:58 AM
Adaptive Biotechnologies (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
10/11/2024
3:14 PM
Adaptive Biotechnologies (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SC 13G/A
10/10/2024
4:47 PM
Adaptive Biotechnologies (Issuer)
BOBULSKY SUSAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
3:27 PM
Adaptive Biotechnologies (Issuer)
Taylor Stacy L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:18 PM
Adaptive Biotechnologies (Subject)
Taylor Stacy L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2024
3:30 PM
Adaptive Biotechnologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
3:15 PM
Adaptive Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2024
3:22 PM
Adaptive Biotechnologies (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SC 13G
05/24/2024
11:01 AM
Adaptive Biotechnologies (Filer)
Form DEFA14A
05/17/2024
5:35 PM
Adaptive Biotechnologies (Issuer)
PISKEL KYLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
4:29 PM
Adaptive Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2024
3:30 PM
Adaptive Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
4:55 PM
Adaptive Biotechnologies (Issuer)
NEUPERT PETER M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:45 PM
Adaptive Biotechnologies (Issuer)
OWEN KATEY EINTERZ (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:46 PM
Adaptive Biotechnologies (Issuer)
Pellini Michael J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:38 PM
Adaptive Biotechnologies (Issuer)
BOBULSKY SUSAN (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/06/2024
6:39 PM
Adaptive Biotechnologies (Issuer)
BOBULSKY SUSAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:40 PM
Adaptive Biotechnologies (Issuer)
ROBINS CHAD M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:40 PM
Adaptive Biotechnologies (Issuer)
PETERSON TYCHO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:41 PM
Adaptive Biotechnologies (Issuer)
ROBINS HARLAN S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:41 PM
Adaptive Biotechnologies (Issuer)
RUBINSTEIN JULIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:42 PM
Adaptive Biotechnologies (Issuer)
BENZENO SHARON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:42 PM
Adaptive Biotechnologies (Issuer)
LO FRANCIS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:42 PM
Adaptive Biotechnologies (Issuer)
Taylor Stacy L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:43 PM
Adaptive Biotechnologies (Issuer)
PISKEL KYLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:43 PM
Adaptive Biotechnologies (Issuer)
GRIFFIN MICHELLE RENEE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:45 PM
Adaptive Biotechnologies (Issuer)
HERSHBERG ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:45 PM
Adaptive Biotechnologies (Issuer)
NEUPERT PETER M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
9:23 AM
Adaptive Biotechnologies (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13G/A
01/29/2024
3:00 PM
Adaptive Biotechnologies (Subject)
ARK Investment Management LLC (Filed by)
Form SC 13G/A
11/20/2023
4:30 PM
Adaptive Biotechnologies (Issuer)
PISKEL KYLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ADPT) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners